Rothschild & Co Asset Management US’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAT
ACH
AAM
GL
SGCM
PCM
Rothschild & Co Asset Management US's BEAT Position: Q4 2020 in Review
Rothschild & Co Asset Management US sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 344,663 shares — an estimated $15.7M sold.
Rothschild & Co Asset Management US first reported a position in BEAT in Q2 2017 and held it in 14 quarters. The position peaked at $25.6M in Q4 2019. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.
- Rothschild & Co Asset Management US reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
- Rothschild & Co Asset Management US sold 344,663 BioTelemetry, Inc. shares in Q4 2020, an estimated $15.7M.
- Rothschild & Co Asset Management US first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 14 quarters.
- Rothschild & Co Asset Management US's BioTelemetry, Inc. position peaked at $25.6M in Q4 2019.
- 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.
Based on Rothschild & Co Asset Management US's 13F filing for Q4 2020, filed 8 Feb 2021.